146 related articles for article (PubMed ID: 17460278)
1. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.
Mott KR; Osorio Y; Maguen E; Nesburn AB; Wittek AE; Cai S; Chattopadhyay S; Ghiasi H
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2185-93. PubMed ID: 17460278
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera.
Ghiasi H; Perng GC; Nesburn AB; Wechsler SL
Virus Res; 2000 Jul; 68(2):137-44. PubMed ID: 10958985
[TBL] [Abstract][Full Text] [Related]
3. HSV-1 antigens and DNA in the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis.
Garweg JG; Russ CE; Schellhorn M; Böhnke M; Halberstadt M
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):734-9. PubMed ID: 12827375
[TBL] [Abstract][Full Text] [Related]
4. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
6. Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8
Jaggi U; Wang S; Tormanen K; Matundan H; Ljubimov AV; Ghiasi H
Front Immunol; 2018; 9():2895. PubMed ID: 30581441
[TBL] [Abstract][Full Text] [Related]
7. Immunisation against HSV-1 keratitis with a synthetic gD peptide.
Heiligenhaus A; Wells PA; Foster CS
Eye (Lond); 1995; 9 ( Pt 1)():89-95. PubMed ID: 7713256
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
9. [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis].
Heiligenhaus A; Jayaraman S; Soukiasian S; Dorf M; Foster CS
Ophthalmologe; 1995 Aug; 92(4):484-91. PubMed ID: 7549333
[TBL] [Abstract][Full Text] [Related]
10. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.
Ho DW; Field PR; Irving WL; Packham DR; Cunningham AL
J Clin Microbiol; 1993 Dec; 31(12):3157-64. PubMed ID: 7508453
[TBL] [Abstract][Full Text] [Related]
11. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation.
Shoji J; Sakimoto T; Inada N; Kamei Y; Matsubara M; Takamura E; Sawa M
Jpn J Ophthalmol; 2016 Jul; 60(4):294-301. PubMed ID: 27126382
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
16. The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Inoue Y; Tano Y; Shimomura Y; Fujisawa Y; Aono A; Hayashi K
Jpn J Ophthalmol; 2002; 46(4):370-76. PubMed ID: 12225814
[TBL] [Abstract][Full Text] [Related]
17. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.
Whitbeck JC; Huang ZY; Cairns TM; Gallagher JR; Lou H; Ponce-de-Leon M; Belshe RB; Eisenberg RJ; Cohen GH
J Virol; 2014 Jul; 88(14):7786-95. PubMed ID: 24789783
[TBL] [Abstract][Full Text] [Related]
18. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
19. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
[TBL] [Abstract][Full Text] [Related]
20. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]